Corbus Pharmaceuticals Holdings, Inc. (LON: 0SZI)

Corbus Pharmaceuticals Holdings Statistics

Total Valuation

Corbus Pharmaceuticals Holdings has a market cap or net worth of GBP 112.24 million. The enterprise value is -14.22 million.

Market Cap	112.24M
Enterprise Value	-14.22M

Important Dates

The next estimated earnings date is Tuesday, March 11, 2025.

Earnings Date	Mar 11, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+110.46%
Shares Change (QoQ)	+8.70%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	7.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	1.00
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	0.49
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.84, with a Debt / Equity ratio of 0.02.

Current Ratio	13.84
Quick Ratio	13.71
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-16.78

Financial Efficiency

Return on equity (ROE) is -51.32% and return on invested capital (ROIC) is -32.59%.

Return on Equity (ROE)	-51.32%
Return on Assets (ROA)	-28.82%
Return on Capital (ROIC)	-32.59%
Revenue Per Employee	n/a
Profits Per Employee	-1.52M
Employee Count	19
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +62.44% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+62.44%
50-Day Moving Average	14.89
200-Day Moving Average	35.10
Relative Strength Index (RSI)	36.63
Average Volume (20 Days)	966

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	8.30

Income Statement

Revenue	n/a
Gross Profit	-22.69M
Operating Income	-34.48M
Pretax Income	-28.87M
Net Income	-28.87M
EBITDA	-34.04M
EBIT	-34.48M
Earnings Per Share (EPS)	-3.22

Balance Sheet

The company has 118.90 million in cash and 2.69 million in debt, giving a net cash position of 116.21 million.

Cash & Cash Equivalents	118.90M
Total Debt	2.69M
Net Cash	116.21M
Net Cash Per Share	n/a
Equity (Book Value)	112.29M
Book Value Per Share	9.22
Working Capital	111.37M

Cash Flow

Operating Cash Flow	-27.50M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Corbus Pharmaceuticals Holdings does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-110.46%
Shareholder Yield	-110.46%
Earnings Yield	-25.73%
FCF Yield	n/a

Stock Splits

The last stock split was on February 14, 2023. It was a reverse split with a ratio of 0.0333333333.

Last Split Date	Feb 14, 2023
Split Type	Reverse
Split Ratio	0.0333333333

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a